PASG NASDAQ
Passage Bio, Inc.
1W: -14.2%
1M: -10.6%
3M: -12.3%
YTD: -64.8%
1Y: -49.3%
3Y: -69.0%
5Y: -98.0%
$4.12
-0.08 (-1.93%)
Weekly Expected Move ±6.7%
$4
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-04-06
Earliest Filing
2024-08-01
Latest Filing
partner: 3
Counterparties (Filed by PASG)
3 relationshipsCompanies named in PASG's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Gemma Biotherapeutics, Inc. | — | partner | Entered into sublicense, collaboration, and transition services agreements for outlicensing genetic medicine programs. | 2024-08-01 | View |
| University of Pennsylvania | — | partner | Amended research, collaboration, and licensing agreement regarding terminated funding and research programs. | 2024-08-01 | View |
| Catalent Maryland, Inc. | — | partner | Amended collaboration and development agreements for manufacturing of drug substance and product. | 2023-04-06 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-03 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-24 | Material Agreement; Termination of Agreement; Unregistered Equity Sales; Change in Control; Officer/ | Agreement | View |
| 2026-05-27 | Termination of Agreement | View | |
| 2026-05-26 | Shareholder Vote | View | |
| 2026-04-28 | Exit/Disposal Costs | View | |
| 2026-04-20 | Regulation FD; Exhibits | View | |
| 2026-03-10 | Termination of Material Definitive Agreement | View | |
| 2026-03-03 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-18 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-29 | Other Events | View | |
| 2025-07-14 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-06-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-30 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-31 | Notice of Delisting or Transfer | View | |
| 2025-01-10 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Ma | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR